Dr. Adam Muzychuk

03/20/2026

Six perfect days in India 🇮🇳 my favourite country I’ve ever visited. Thank you AIOS for the invitation.

Incredible and busy days of lectures, instructional courses, and learning from colleagues on another continent doing unbelievable work in surgery.

I’ll always remember the warmth of the All India Ophthalmology Society, being welcomed into their professional community and rich cultural traditions, and coming away with new friendships and professional relationships.

Not pictured: me at one of the galas in full Indian National Dress.

03/20/2026

Six perfect days in India 🇮🇳 my favourite country I’ve ever visited. Thank you AIOS for the invitation.

03/16/2026

NEW PUBLICATION - 16 March 2026

We know from the work of Julie and Steve Schallhorn that just 0.50D of residual astigmatism is visually significant and deserves attention in surgical planning. This paper demonstrates that with basic equipment already available in your office and OR, you can reliably reduce even the smallest amounts of visually-significant astigmatism with ultra-low cylinder power toric IOLs, and further supports that the rule-of-thumb that we should only treat >1.00D of pre-operative cylinder is not supported by contemporary evidence.

For surgeons: The treatable population is larger than keratometry alone suggests. Even a near-plano eye on keratometry can be predicted to benefit from a 0.90D or 1.00D toric IOL once posterior corneal astigmatism and surgically induced astigmatism are accounted for. Run contemporary toric calculators on every eye. This data supports routine toric IOL planning using only the basic equipment already in your practice. An IOLMaster 500, a placido-disk topographer, and manual marking were sufficient to achieve 0.59D of cylinder reduction in a real-world consecutive case series. No intraoperative aberrometry. No digital toric alignment. The barrier is lower than you think.

For industry partners: Regardless of which platform you support, your surgeons may be systematically underutilizing your ultra-low (

02/01/2026

This weekend, we welcomed Julie Schallhorn, MD (UCSF) and Kamran Riaz, MD (Dean McGee Eye Institute, OKC) to Banff as guest faculty for our provincial society meeting. Two of the most influential surgeon-scientists in the world whose work continues to shape modern cataract and refractive surgery. Thank you, Julie and Kam 🙏

01/07/2026

Full circle moment.

Featured in the alumni publication of St. Paul’s College at the University of Manitoba, where it all began in undergrad. Grateful for the friends, mentors, and opportunities that shaped the early chapters.

Fun fact: during my year as head of the Students’ Association, our team started the beer gardens that still run every fall 🍻

12/12/2025

18 years since I last walked into the Manitoba Club, never thought I’d be invited here to discuss surgery. Thanks to Johnson & Johnson Surgical Vision for the invitation, my good friend and industry partner Sam Chang, and my colleagues in Manitoba for braving the winter storm.

2h45 minutes straight of presentations, discussion and Q&A, a career record. In spite of the song by Winnipeg’s fourth best band, I love this city.

11/23/2025

Late lunch.

11/22/2025

Could not have had a better night celebrating with friends. Thank you everyone 🙏

11/21/2025

Last night was surreal. Congrats to the Class of 2025 - some of the most inspiring people I’ve met, and incredible people to have a beer with in the ready room. The highlight might be the start of our 40-person group chat.

11/06/2025

Laser with one of the best teams in refractive surgery. Grateful for all the time I get to spend with our patients and this crew in the OR 💪

10/28/2025

When you spend most of your time in scrubs or at research meetings, it’s surreal to be featured outside of academic journals. Honoured to be part of Avenue Calgary’s Top 40 Under 40 this year.

10/21/2025

The first randomized, controlled clinical trial evaluating what is now known as enVista Envy, a continuous full-range of vision IOL technology, marks a major advancement in cataract and refractive surgery.

This innovation has transformed the field by reducing bothersome dysphotopsias such as glare, halos, and starbursts, while maintaining excellent vision across all distances.

This publication represents the collaborative work of 9 surgeons and research teams across 9 clinical sites, supported by the outstanding team at Bausch + Lomb and the professional and organized CRO team at Promedica.

Congratulations to all involved.

This open article compares the visual performance and patient-reported outcomes after bilateral implantation of a new full visual range intraocular lens or its monofocal version.

Read the full article: https://journals.lww.com/jcrs/fulltext/2025/10000/efficacy_and_safety_evaluation_of_a_new_full.6.aspx